Funded Tech Companies
Cytovation
Wondering who provided funding to Cytovation? Sandwater and Canica joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Cytovation
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Solheimsgaten 11
Bergen, 5058
NO
Bergen, 5058
NO
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Cytovation is a clinical stage biotech developing CyPep-1, the first synthetic peptide engineered to selectively target tumor cell membranes based on their altered molecular composition. CyPep-1 lyses the cell membranes, exposes antigenic material from within the cancer cells, and induces a tumor-specific immune response. The described mode of action is effective across cancer types and highly synergistic with checkpoint inhibitors.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/23/2025
Financing History
Management Team
Title
Name
Email & Social
Chairman
Per Lønning
Chief Executive Officer
Lars Prestegarden
Chief Operating Officer
Federico Grego
Co-Founder
Rolf Bjerkvig
Company Investors
- Sandwater
- Canica
Browse more funded tech companies:
Cytovance Biologics | Cytracom
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs